Affirm Holdings Surges 12.62% Amid Strong Momentum, But Valuation Concerns Persist

Technical Analysis

Affirm Holdings, Inc. (AFRM) closed at $74.79 on August 4, 2025, posting a strong intraday gain of 12.62%. The stock showed robust upward momentum, breaking above its 50-day ($63.09) and 200-day ($57.68) moving averages, signaling a bullish trend. The RSI at 70 is at the brink of overbought levels, indicating potential short-term caution. The MACD remains slightly negative (-0.04), suggesting the longer-term momentum has yet to turn decisively bullish but could be improving given recent price strength. Average True Range (ATR) of 4.49 suggests moderate volatility, consistent with recent price swings. Volume at 9.86 million exceeds the 6.64 million average, confirming strong buying interest.

Price action indicates key support around $68.06. There is no clear resistance above the current price within the immediate trading range, with the 52-week high at $82.53 acting as a longer-term upper target. A stop-loss threshold indicated near $71.86 supports capital protection against downside risk.

For the next trading day (August 5), given the positive price surge and elevated volume, continuation of bullish momentum is plausible, although RSI nearing 70 may lead to a short-term pullback or consolidation.

Over the upcoming week, the general upward trend supported by improved technical conditions and increased market interest could continue, especially if no negative news emerges before the earnings release on August 28.

Fundamental Analysis

Affirm Holdings presents a challenging fundamental profile. The trailing twelve months (TTM) earnings per share (EPS) is negative at -$0.19, translating to a severely negative price-to-earnings (PE) ratio of -393.63, reflecting ongoing losses typical of high-growth fintech firms. The discounted cash flow (DCF) valuation is negative (-43.25), indicating the current earnings and anticipated cash flows do not support the current market price intrinsically.

Market capitalization stands at $24.13 billion, reflecting substantial investor confidence despite the lack of profitability. The target price consensus is $69, below the current close, and the analyst consensus favors a “Buy” with 14 buy ratings, 11 hold, and 2 sell, highlighting a generally optimistic outlook on long-term growth potential despite short-term valuation concerns.

The company's positioning in the Buy-Now-Pay-Later (BNPL) segment benefits from inflationary pressures driving consumer credit usage, which may sustain growth. However, the near-term financials lack earnings stability, and critical upcoming earnings on August 28 will likely be a catalyst for the stock’s valuation recalibration.

Intrinsic Value and Long-Term Potential

The negative DCF and persistent net losses indicate current overvaluation based strictly on fundamental measures. However, Affirm’s substantial market share in BNPL and innovation in consumer financing point to significant growth prospects. The stock’s intrinsic value remains uncertain due to unpredictable cash flow generation, but if the company successfully scales and improves profitability, intrinsic value should improve materially in the medium to long term.

Long-term investors should monitor earnings progress and margin improvement closely. The valuation premium appears to price in future growth that is not yet realized.

Overall Evaluation

Affirm’s stock is exhibiting strong technical momentum and positive market sentiment, but valuation is stretched relative to fundamentals. The stock is primarily a growth play exposed to execution risk and market volatility.

Categorized as a Hold: The elevated momentum and optimistic analyst sentiment support continued interest, but caution is warranted due to weak earnings, negative DCF, and proximity to overbought conditions. Investors with a growth tolerance may stay engaged while awaiting fundamental improvements in the upcoming quarters. Short-term trading could exploit momentum swings, but intrinsic valuation gaps temper enthusiasm for an outright Buy.